DycaicoJM, GrantSGN, FeltsK, Neonatal hepatitis induced by alpha-1-antitrypsin: a transgenic mouse model. Science1988;242:1409–1412.
10.
CottrallK, CookP, MowatA.Neonatal hepatitis syndrome and alpha-1-antitrypsin deficiency: an epidemiological study in southwest England. Postgrad Med J1974;50:376–380.
11.
HadchouelM, GautierM.Histopathologic study of the liver in the early cholestatic phase of alpha-1-antitrypsin deficiency. J Pediatr1976;89:211–215.
12.
MorozSP, CutzE, CoxDW, Sass-KortsakA.Liver disease associated with alpha-1 antitrypsin deficiency in childhood. J Pediatr1976;88:19–25.
13.
NebbiaG, HadchouelM, OdievreM, AlagilleD.Early assessment of evolution of liver disease associated with alpha-1-antitrypsin deficiency in childhood. J Pediatr1983;102:661–665.
14.
PittschielerK, MassiG.Liver involvement in infants with PiSZ phenotype of alpha-1-antitrypsin deficiency. J Pediatr Gastroenterol Nutr1992;15:315–318.
15.
AsarianJ, ArchibaldRW, LiebermanJ.Childhood cirrhosis associated with alpha-1-antitrypsin deficiency. A genetic, biochemical, and morphologic study. J Pediatr1975;86:844–850.
16.
LohrHF, SchlaakJF, DienesHP, LorenzJ, Meyer zum BuschenfeldeKH, GerkenG.Liver cirrhosis associated with heterozygous alpha-1-antitrypsin deficiency type Pi MS and autoimmune features. Digestion1995;56:41–45.
17.
HodgesJR, Millward-SadlerGH, BarbatisC, WrightR.Heterozygous MZ alpha-1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. N Engl J Med1981;304:557–560.
18.
PittschielerK, MassiG.Liver involvement in infants with PiSZ phenotype of alpha-1-antitrypsin deficiency. J Pediatr Gastroenterol Nutr1992;15:315–318.
19.
YunisEJ, AgostiniRM, GlewRH. Fine structural observations of the liver in alpha-1-antitrypsin deficiency. Am J Pathol1976;82:265–286.
20.
QizilbashA, Young-PongO.Alpha-1-antitrypsin liver disease differential diagnosis of PAS-positive, diastase-resistant globules in liver cells. Am J Clin Pathol1983;79:697–702.
21.
BuchinoJ.Niemann-Pick type C. Pediatr Pathol1993;13:841–845.
22.
KellyDA, PortmannB, MowatAP, SherlockS, LakeBD. Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. J Pediatr1993;123:242–247.
23.
VanierMT, Rodriguez-LafrasseC, RoussonR, Type C Niemann-Pick disease: biochemical aspects and phenotypic heterogeneity. Dev Neurosci1991;13:307–314.
24.
RutledgeJ.Progressive neonatal liver failure due to type C Niemann-Pick disease. Pediatr Pathol1989;9:779–784.
25.
EllederM, HrodekJ, CihulaJ.Niemann-Pick disease: lipid storage in bone marrow machrophages. Histochem J1983;15:1065–1077.
26.
GoezH, MeironD, HorowitzJ, Infantile Refsum disease: neonatal cholestatic jaundice. Presentation of a peroxisomal disorder. J Pediatr Gastroenterol Nutr1995; 20:98–101.
27.
PrzyrembelH, WandersRJA, Van RoermundCW. Di- and trihyroxycholestanoic acidemia with hepatic failure. J Inherit Metab Dis1990;13:367–370.
28.
VersmoldH, BremerH, HerzogV, A metabolic disorder similar to Zellweger syndrome with hepatic acatalasia and absence of peroxisomes, altered content and redox state of cytochromes, and infantile cirrhosis with hemosiderosis. Eur J Pediatr1977;124:261–275.
29.
MonnensL, BakkerenJ, ParmentierG, Disturbances in bile acid metabolism of infants with the Zellweger (cerebro-hepato-renal) syndrome. Eur J Pediatr1980;133:31–35.
30.
Muller-HockerJ, WaltherJ, BiseK, PongratzD, HubnerG.Mitochondrial myopathy with loosely coupled oxidative phosphorylation in a case of Zellweger syndrome. Virchows Arch B Cell Pathol Incl Mol Pathol1984;45:125–138.
31.
DanksD, TippettP, AdamsC, CampbellP.Cerebro-hepato-renal syndrome of Zellweger. A report of eight cases with comments upon the incidence, the liver lesion, and a fault in pipecolic acid metabolism. J Pediatr1975;86:382–387.
32.
SmithD, OpitzJ, InhornL.A syndrome of multiple developmental defects including polycystic kidneys and intrahepatic biliary dysgenesis in 2 siblings. J Pediatr1965;67:617–624.
33.
OpitzJ, ZuRheinG, VitaleL, The Zellweger syndrome (cerebro-hepato-renal syndrome). Birth Defects1969;5:144–158.
34.
RichardsonS, BishopR, SmithA.Reovirus serotype 3 infection in infants with extrahepatic biliary atresia or neonatal hepatitis. Hum Pathol1994;19:603–605.
35.
BullLN, CarltonVE, StrickerNL, Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology1997;26:155–164.
AagenaesO, van der HagenCB, RefsumS.Hereditary recurrent intrahepatic cholestasis from birth. Arch Dis Child1968;43:646–657.
38.
SharpH, KrivitW.Hereditary lymphadema and obstructive jaundice. J Pediatr1971;78:49–56.
39.
SchubertW, PartinJ, PartinJ.Congenital cholestasis: clinical and ultrastructural study. In: BerenbergSR, ed. Liver Diseases in Infancy and Childhood. Baltimore: Williams & Wilkins, 1976;148–162.
40.
ByrneJ, HarrodM, FriedmanJ, Howard-PeeblesP.del (20p) with manifestations of arteriohepatic dysplasia. Am J Med Genet1986;24:673–678.
41.
SpinnerN, FortinaP, GeninA, TaubR.Cytogenetically balanced t(2:20) in a two-generation family with Alagille syndrome: cytogenetic and molecular studies. Am J Hum Genet1994;55:238–243.
42.
LiL, KrantzID, DengY, Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet1997;16:243–251.
43.
HadchouelM, HugonR, GautierM.Reduced ratio of portal tracts to paucity of intrahepatic bile ducts. Arch Pathol Lab Med1978;102:402.
44.
DahmsB, PetrelliM, WylieR, Arteriohepatic dysplasia in infancy in childhood: a longitudinal study of six patients. Hepatology1982;2:350–358.
45.
WitzlebenC, PiccoliD, SetchellK.A new category of causes of intrahepatic cholestasis. J Pediatr Pathol1992; 12:269–274.
46.
HorslenS, LawsonA, MaloneM, 3-beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency: effect of chenodeoxycholic acid therapy on liver histology. J Inherit Metab Dis1992;15:38–46.
47.
DaughertyC, SetchellK, HeubiJ, Resolution of hepatic biopsy alterations in three siblings with bile acid treatment of an inborn error of bile acid metabolism. Hepatology1993;18:1096–1101.
48.
BrittonRS, BaconBR. Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology1994;41:343–348.
49.
SchaffnerF, SternliebI, BarkaT, Hepatocellular changes in Wilson's disease: histochemical and electron microscopic studies. Am J Pathol1962;41:315–328.
50.
AndersonP, PopperH.Changes in hepatic structure in Wilson's disease. Am J Pathol1960;36:483–498.
51.
ScenibergI, SternliebI.The liver in Wilson's disease. Gastroenterology1995;37:550–564.
52.
SternliebI, ScheinbergI.Chronic hepatitis as a first manifestation of Wilson's disease. Ann Intern Med1972; 76:59–64.
53.
SternliebI.Mitochondrial and fatty changes in hepatocytes of patients with Wilson's disease. Gastroenterology1968;55:354–367.
54.
DaviesSE, WilliamsR, PortmannB.Hepatic morphology and histochemistry of Wilson's disease presenting as fulminant hepatic failure: a study of 11 cases. Histopathology1989;15:385–394.
55.
EnomotoK, IshibashiH, IrieK, Fulminant hepatic failure without evidence of cirrhosis in a case of Wilson's disease. Jpn J Med1989;28:80–84.
56.
SternliebI.Characterization of the ultrastructural changes of hepatocytes in Wilson's disease. Birth Defects1968;4:92.
57.
GoldfischerS, PopperH, SternliebI.The significance of variations in the distribution of copper in liver disease. Am J Pathol1980;99:715–730.
58.
EvansJ, NewmanS, SherlockS.Observations on copper-associated protein in childhood liver disease. Gut1980;21: 970–976.
59.
LudwigJ, MoyerTP, RakelaJ.The liver biopsy diagnosis of Wilson's disease. Methods in pathology. Am J Clin Pathol1994;102:443–446.
60.
ScheinbergI, SternliebI.The liver in Wilson's disease. Gastroenterology1959;37:550–564.
JoshiVV. Indian childhood cirrhosis. Perspect Pediatr Pathol1987;11:175–192.
63.
PanditA, BhaveS.Present interpretation of the role of copper in Indian childhood cirrhosis. Am J Clin Nutr1996;63:830S–835S.
64.
PradhanAM, BhaveSA, JoshiVV, BavdekarAR, PanditAN, TannerMS. Reversal of Indian childhood cirrhosis by D-penicillamine therapy. J Pediatr Gastroenterol Nutr1995;20:28–35.
65.
PopperJ, GoldfischerS, SternliebI, Cytoplasmic copper and its toxic effects: studies in Indian childhood cirrhosis. Arch Dis Child1979;62:1118–1124.
66.
SethiS, GroverS, KhodaskarMB. Role of copper in Indian childhood cirrhosis. Ann Trop Paediatr1993;13:3–5.
67.
O'NeillN, TannerM.Uptake of copper from brass vessels by bovine milk and its relevance to Indian childhood cirrhosis. J Pediatr Gastroenterol Nutr1989;9:167–172.
68.
TannerMS, PortmannB, MowatAP, Increased hepatic copper concentration in Indian childhood cirrhosis. Lancet1979;1:1203–1205.
69.
PortmannB, TannerMS, MowatAP, WilliamsR.Orcein-positive liver deposits in Indian childhood cirrhosis. Lancet1978;1:1338–1340.
FuruyaKN, RobertsEA, CannyGJ, PhillipsMJ. Neonatal hepatitis syndrome with paucity of interlobular bile ducts in cystic fibrosis. J Pediatr Gastroenterol Nutr1991;12:127–130.
72.
RosensteinB, OppenheimerE.Prolonged obstructive jaundice and giant cell hepatitis in an infant with cystic fibrosis. J Pediatr1978;93:1060–1061.
73.
AlagilleD, OdievreM, GautierM, DommerguesJ.Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental and sexual development and cardiac murmur. J Pediatr1975; 86:63–71.
MarkowitzJ, DaumF, KahnE, Arteriohepatic dysplasia. I. Pitfalls in diagnosis and management. Hepatology1983;1:74–76.
76.
ResnickJM, WhitleyCB, LeonardAS, KrivitW, SnoverDC. Light and electron microscopic features of the liver in mucopolysaccharidosis. Hum Pathol1994;25:276–286.
77.
HardwickD, DimmickJ.Metabolic cirrhoses of infancy and early childhood. Perspect Pediatr Pathol1976;3:103–144.
78.
ParfreyN, HutchinsG.Hepatic fibrosis in the mucopoly-saccharidoses. Am J Med1986;81:825–829.
79.
CallahanW, LorinczA.Hepatic ultrastructure in the Hurler syndrome. Am J Pathol1966;48:277–298.
80.
FredricksonD, SloanH.Sphingomyelin lipidosis: Niemann-Pick disease. In: StanburyJB, SyngaardenJB, FredricksonDS, eds. The Metabolic Basis of Inherited Disease, 3rd ed. New York: McGraw-Hill, 1972;783.
81.
LongRG, LakeBD, PettitJE, ScheuerPJ, SherlockS.Adult Niemann-Pick disease: its relationship to the syndrome of the sea-blue histiocyte. Am J Med1977;62:627–635.
HardikarW, SuchyF.Lysosomal storage disorders. In: SuchyFJ, ed. Liver Disease in Children. St. Louis: Mosby, 1994;819–834.
84.
GilbertEF, DawsonG, RheinGMz, OpitzJM, Spranger. I-cell disease, mucolipidosis II. Pathological, histochemical, ultrastructural and biochemical observations in four cases. Z Kinderheilkunde1973;114:259–292.
85.
RichesW, SuruckerE.A severe infantile mucoliposis: clinical, biochemical and pathologic features. Arch Pathol Lab Med1983;107:147–152.
86.
HaleLP, van de VenCJ, WengerDA, BradfordWD, KahlerSG. Infantile sialic acid storage disease: a rare cause of cytoplasmic vacuolation in pediatric patients. Pediatr Pathol Lab Med1995;15:443–453.
87.
KlennPJ, RubinR.Hepatic fibrosis associated with hereditary cystinosis: a novel form of noncirrhotic portal hypertension. Mod Pathol1994;7:879–882.
88.
ScottoJM, StralinHG. Ultrastructure of the liver in a case of childhood cystinosis. Virchows Arch A Pathol Anat Histol1977;377:43–48.
89.
GillanJE, LowdenJA, GaskinK, CutzE.Congenital ascites as a presenting sign of lysosomal storage disease. J Pediatr1984;104:225–231.
90.
PetrelliM, BlairJD. The liver in GM1 gangliosidosis types 1 and 2. A light and electron microscopical study. Arch Pathol1975;99:111–116.
91.
MillerR, BialerM, RogersJ, JohnssonH, AllenR, HennigarC.Wolman disease: a report of a case with multiple studies. Arch Pathol Lab Med1982;106:41–44.
92.
OdievreM, HadchouelM, LandrieuP, AlagilleD, EliotN.Long-term prognosis for infants with hepatic cholestasis and patent extrahepatic biliary tract. Arch Dis Child1981;56:373–376.
93.
ZerbiniC, WeinbergDS, HollisterKA, Perez-AtaydeAR. DNA ploidy abnormalities in the liver of children with hereditary tyrosinemia type I. Correlation with histopathologic features. Am J Pathol1992;140:1111–1119.
94.
ResiboisA.Electron microscopic studies of metachromatic leucodystrophy. IV. Liver and kidney alterations. Pathol Eur1971;6:278–298.
95.
McAdamsAJ, HugG, BoveKE. Glycogen storage disease I to X. Criteria for morphologic diagnosis. Hum Pathol1974;5:463–487.
96.
JevonGP, FinegoldMJ. Reliability of histological criteria in glycogen storage disease of the liver. Pediatr Pathol1994;14:709–721.
CoireCI, QizilbashAH, CastelliMF. Hepatic adenomata in type 1a glycogen storage disease. Arch Pathol Lab Med1987;111:166–169.
99.
BrunelleF, TammamS, OdievreM, ChaumontP.Liver adenomas in glycogen storage disease in children. Ultrasound and angiographic study. Pediatr Radiol1984;14:94–101.
100.
ZangenehF, LimbeckGA, BrownBI, Hepatorenal glycogenosis (type I glycogenosis) and carcinoma of the liver. J Pediatr1969;74:73–83.
101.
BannayanG, DeanW, HowellR.Type IV glycogen storage disease: light microscopic, electron microscopic, and enzyme study. Am J Clin Pathol1976;66:702–709.
102.
LykavierisP, BernardO, HadchouelM.Neonatal cholestasis as the presenting feature in cystic fibrosis. Arch Dis Child1996;75:67–70.
103.
OppenheimerEH, EsterlyJR. Pathology of cystic fibrosis review of the literature and comparison with 146 autopsied cases. Perspect Pediatr Pathol1975;2:241–278.
104.
Cystic Fibrosis Foundation.Patient Registry Annual Data Report. Bethesda, Maryland1995.
105.
TannerMS, TaylorCJ. Liver disease in cystic fibrosis. Arch Dis Child1995;72:281–284.
106.
CohnJ, StrongT, TicciottoM, NairnA, CollinsF, FitzJ.Localisation of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastro-enterology1993;105:1857–1864.
107.
PotterCJ, FishbeinM, HammondS, McCoyK, QualmanS.Can the histological changes of cystic fibrosis-associated hepatobiliary disease be predicted by clinical criteria? J Pediatr Gastroenterol Nutr1997;25:32–36.
108.
JevonG, WongL, DavidsonA.A clinicopathological evaluation of the effects of ursodeoxycholic acidtherapy on the liverin children with cystic fibrosis (abstract). Mod Pathol1997;10:4P.
109.
StrandvikB, HultcrantzR.Liver function and morphology during long-term fatty acid supplementation in cystic fibrosis. Liver1994;14:32–36.
110.
WaltersG, JacobsA, WorwoodM, Iron absorption in normal subjects and patients with idiopathic haemochromatosis: relationship with serum ferritin concentration. Gut1975;16:188–192.
111.
WilliamsR, ManentiF, WilliamsH, Iron absorption in idiopathic haemochromatosis before, during and after venesection therapy. Br Med J1966;2:78–81.
112.
BassettML, HallidayJW, PowellLW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology1986;6:24–29.
113.
DubinI.Idiopathic hemochromatosis and transfusion siderosis. Am J Clin Pathol1955;25:514–542.
114.
PowellLW, KerrJF. The pathology of the liver in hemochromatosis. Pathobiology1975;5:317–337.
115.
DeugnierYM, LorealO, TurlinB, Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology1992;102:2050–2059.
116.
KaikovY, WadsworthL, HassallE, Primary hemochromatosis in children: report of three newly diagnosed cases and review of the pediatric literature. Pediatrics1992;90:37–42.
117.
BloomerJ.The liver in protoporphyria. Hepatology1988; 8:402–407.
118.
RademakersLH, CletonMI, KooijmanC, Baart de laFaille H, van HattumJ.Early involvement of hepatic parenchymal cells in erythrohepatic protoporphyria? An ultrastructural study of patients with and without overt liver disease and the effect of chenodeoxycholic acid treatment. Hepatology1990;11:449–457.
119.
PimstoneNR. Hematologic and hepatic manifestations of the cutaneous porphyrins. Clin Dermatol1985;3:83–102.
120.
NakanumaY, WadaM, KonoN, MiyamuraH, OhtaG.An autopsy case of erythropoietic protoporphyria with cholestatic jaundice and hepatic failure, and a review of literature. Virchows Arch A Pathol Anat Histol1981;393:123–132.
121.
BrugueraM, EsquerdaJE, MascaroJM, PinolJ.Erythropoietic protoporphyria. A light, electron, and polarization microscopical study of the liver in three patients. Arch Pathol Lab Med1976;100:587–589.